The Department of Health and Social Care (DHSC) and the NHS have published an early market engagement to any organisations which are interested in the blood self-sampling/testing services for the build and private Beta phase of the digital NHS Health Check.
The exercise is intended to provide potential bidders with the opportunity to view and comment on the requirements for the blood self-sampling services for the digital NHS Health Check, if they wish to do so. It also aims to enable DHSC to:
- understand more about existing end-to-end pathology services in England that can supply, distribute, receive, analyse and send results from self-sampling or self-testing cholesterol and blood glucose (HbA1c) kits that meet the requirements of the planned digital NHS Health Check.
- inform the blood sampling/testing approach and a potential Invitation to Tender (ITT) to procure the required pathology services for the planned digital NHS Health Check Beta phase.
- inform decisions on the approach to cholesterol and blood glucose sampling/testing for the digital NHS Health Check when considering rollout at scale.
Currently, the intention is to test blood self-sampling and/or self-testing as part of the end-to-end digital NHS Health Check pathway with a small number of eligible participants during the private Beta phase. However, this is dependent on suitable services being available that meet the programme requirements.
For more information and tender documents, please visit https://www.contractsfinder.service.gov.uk/notice/0da7496a-3b09-454f-aeee-6bdfa10d2970
Closing date for the exercise is 19 January.
